Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.
D000818:Animals; D002264:Carboxylic Acids / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000494:pharmacology; D004195:Disease Models, Animal; D005215:Fasting; D006949:Hyperlipidemias / Q000139:chemically induced*; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D009281:Naphthalenes / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D010636:Phenols / Q000494:pharmacology; D011134:Polysaccharides / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D051381:Rats; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000097:blood; D013974:Thyroxine / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood; D014308:Triparanol / Q000494:pharmacology
D002264:Carboxylic Acids; D000960:Hypolipidemic Agents; D009281:Naphthalenes; D009539:Nicotinic Acids; D010080:Oxazoles; D010636:Phenols; D011134:Polysaccharides; D011759:Pyrrolidines; D013501:Surface-Active Agents; D014280:Triglycerides; D014308:Triparanol; D002784:Cholesterol; D002994:Clofibrate; D013974:Thyroxine